SkylineDX

Rotterdam, Netherlands Founded: 2005 • Age: 21 yrs
Gene expression profiling tests are provided for personalized medicine.
Request Access

About SkylineDX

SkylineDX is a company based in Rotterdam (Netherlands) founded in 2005.. SkylineDX offers products and services including Merlin™ Test and SKY92. SkylineDX operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.

  • Headquarter Rotterdam, Netherlands
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Skylinedx Usa, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SkylineDX

SkylineDX offers a comprehensive portfolio of products and services, including Merlin™ Test and SKY92. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Assesses gene expression for melanoma risk in patients.

Evaluates biomarkers for hemato-oncology conditions.

People of SkylineDX
Headcount 50-200
Employee Profiles 43
Board Members and Advisors 5
Employee Profiles
People
Monique van Steen-Luijcks
Lab Technician
People
Jhoel Parducho
Reimbursement Manager
People
Phil Todd
Customer Service Associate
People
Jeff Chen
Clinical Laboratory Scientist, General Supervisor

Unlock access to complete

Board Members and Advisors
people
Erik Esveld
Supervisory Board Member
people
Stefan Sleijfer
Supervisory Board Member
people
Alexander M.M. Eggermont
Medical Advisor Melanoma & Dermatology
people
Ton Stam
Chairman

Unlock access to complete

Funding Insights of SkylineDX

  • Total Funding
  • Total Rounds 6
  • Last Round
  • First Round
  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2021 Amount Seed - SkylineDX Valuation Novalis LifeSciences
Jan, 2020 Amount Grant - SkylineDX Valuation

investors

Nov, 2016 Amount Grant - SkylineDX Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in SkylineDX

SkylineDX has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, European Union and Novalis LifeSciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment and advisory services are provided for life sciences.
Founded Year Domain Location
Life-Sciences & Offline focused VC firm funding companies in Netherlands
Founded Year Domain Location
EQT is recognized as a global investment organization focused on value creation.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by SkylineDX

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - SkylineDX

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Skylinedx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of SkylineDX

SkylineDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
domain founded_year HQ Location
MicroRNA-based therapeutics are developed for treating multiple diseases.
domain founded_year HQ Location
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
domain founded_year HQ Location
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
domain founded_year HQ Location
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
domain founded_year HQ Location
Therapeutics for aging diseases are developed by targeting senescent cells.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about SkylineDX

When was SkylineDX founded?

SkylineDX was founded in 2005 and raised its 1st funding round 4 years after it was founded.

Where is SkylineDX located?

SkylineDX is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.

Who is the current CEO of SkylineDX?

Dharminder Chahal is the current CEO of SkylineDX.

What does SkylineDX do?

SkylineDX was founded in 2005 and is based in Rotterdam, Netherlands. Gene expression profiling tests for personalized medicine are offered in the biotechnology sector. A proprietary Profiler platform is employed, featuring a secure data analysis system for transcriptomics. MMprofiler is utilized for risk stratification of multiple myeloma patients through 92 genes. AML Profiler supports subtyping of acute myeloid leukemia. APprofiler for angina pectoris detection is under development.

Who are the top competitors of SkylineDX?

SkylineDX's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.

What products or services does SkylineDX offer?

SkylineDX offers Merlin™ Test and SKY92.

Who are SkylineDX's investors?

SkylineDX has 5 investors. Key investors include European Commission, European Union, Novalis LifeSciences, Van Herk Groep, and EQT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available